Viking Therapeutics, Inc. short interest in 2022
In 2022, Viking Therapeutics, Inc.'s disclosed short interest ran from 4.65% of shares outstanding on 14 Jan 2022 to 2.47% on 15 Dec 2022, a change of -2.18 percentage points. The year's high was 6.06% on 31 May 2022 and its low 2.31% on 30 Nov 2022, averaging 3.94% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 5.72 days on 15 Mar 2022. Full history: Viking Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 4.65% (14 Jan 2022)
- End of year
- 2.47% (15 Dec 2022)
- Change
- -2.18 pp
- High
- 6.06% (31 May 2022)
- Low
- 2.31% (30 Nov 2022)
- Average
- 3.94%
- Highest days to cover
- 5.72 (15 Mar 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 4.65% | 3.24 | |
| 31 Jan 2022 | 5.52% | 2.85 | |
| 15 Feb 2022 | 5.29% | 3.67 | 10-K filed, results (8-K) |
| 28 Feb 2022 | 5.56% | 3.82 | |
| 15 Mar 2022 | 5.70% | 5.72 | |
| 31 Mar 2022 | 4.55% | 2.79 | |
| 14 Apr 2022 | 4.72% | 4.71 | |
| 29 Apr 2022 | 4.98% | 4.00 | 10-Q filed, results (8-K) |
| 13 May 2022 | 5.80% | 5.13 | |
| 31 May 2022 | 6.06% | 5.12 | |
| 15 Jun 2022 | 5.95% | 4.63 | |
| 30 Jun 2022 | 3.50% | 1.46 | |
| 15 Jul 2022 | 3.19% | 2.06 | |
| 29 Jul 2022 | 2.83% | 1.99 | 10-Q filed, results (8-K) |
| 15 Aug 2022 | 2.73% | 2.79 | |
| 31 Aug 2022 | 2.64% | 5.40 | |
| 15 Sep 2022 | 2.51% | 4.74 | |
| 30 Sep 2022 | 2.45% | 3.66 | |
| 14 Oct 2022 | 2.33% | 3.19 | |
| 31 Oct 2022 | 2.47% | 1.46 | 10-Q filed, results (8-K) |
| 15 Nov 2022 | 2.35% | 1.72 | |
| 30 Nov 2022 | 2.31% | 2.75 | |
| 15 Dec 2022 | 2.47% | 3.35 |
See also: Viking Therapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.